Figure 1.
Candidate LCH precursors: myeloid lineages in peripheral blood and tissue. (A) CD45+Lineage−HLA-DR+ subsets from PBMCs (lineage contains CD3, CD19, CD20, and CD56). (i) CD14+CD16− classical monocytes. (ii) CD14lowCD16+ nonclassical monocytes. (iii) CD11c−CD123+ pDCs. (iv) CD11clowCD141+ mDCs (DC1). (v) CD11c+CD1c+ mDCs (DC2). (B) CD45+HLA-DR+ subsets from tissues. (i) AF+ macrophages. (ii) CD1a+Langerin+ LCs. (iii) CD11c+CD14+ monocytes-macrophages (Mono-Mac). (iv) CD11clowCD141+ mDCs. (v) CD11c+CD1c+ mDCs. SSC-A, side scatter area.

Candidate LCH precursors: myeloid lineages in peripheral blood and tissue. (A) CD45+LineageHLA-DR+ subsets from PBMCs (lineage contains CD3, CD19, CD20, and CD56). (i) CD14+CD16 classical monocytes. (ii) CD14lowCD16+ nonclassical monocytes. (iii) CD11cCD123+ pDCs. (iv) CD11clowCD141+ mDCs (DC1). (v) CD11c+CD1c+ mDCs (DC2). (B) CD45+HLA-DR+ subsets from tissues. (i) AF+ macrophages. (ii) CD1a+Langerin+ LCs. (iii) CD11c+CD14+ monocytes-macrophages (Mono-Mac). (iv) CD11clowCD141+ mDCs. (v) CD11c+CD1c+ mDCs. SSC-A, side scatter area.

Close Modal

or Create an Account

Close Modal
Close Modal